Carbapenemases as factors of Resistance to Antibacterial Drugs
Antibiotic drugs are used to treat and prevent bacterial infections around the world. The emergence and spread of bacterial resistance to carbapenems is currently a real threat that determines the need for its timely detection and suppression. Carbapenem-resistant Enterobacteriaceae, Pseudomonas a...
Saved in:
Main Author: | A. V. Nevezhina |
---|---|
Format: | article |
Language: | RU |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fba17456b56f4fb698b8ecb470d259b9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
by: Melissa D. Barnes, et al.
Published: (2017) -
Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre
by: Uma Chaudhary, et al.
Published: (2018) -
Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Clinical Isolates
by: Shuo Lu, et al.
Published: (2020) -
Epidemiology of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacterales in the Greater Mekong Subregion: A Systematic-Review and Meta-Analysis of Risk Factors Associated With Extended-Spectrum Beta-Lactamase and Carbapenemase Isolation
by: Shweta R. Singh, et al.
Published: (2021) -
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
by: Yanfang Feng, et al.
Published: (2021)